Valuation: Simulations Plus, Inc.

Market Cap 37Cr 32Cr 30Cr 28Cr 52Cr 3.53TCr 53Cr 357.18Cr 140.09Cr 1.73TCr 138.53Cr 135.5Cr 5.99TCr P/E 2026 *
43.4x
P/E 2027 * 39.9x
Enterprise Value 37Cr 32Cr 30Cr 28Cr 52Cr 3.53TCr 53Cr 357.18Cr 140.09Cr 1.73TCr 138.53Cr 135.5Cr 5.99TCr EV / Sales 2026 *
4.51x
EV / Sales 2027 * 4.28x
Free-Float
82.77%
Yield 2026 *
-
Yield 2027 * -
1 day+0.05%
1 week-0.63%
Current month-0.35%
1 month+11.45%
3 months+40.89%
6 months-8.18%
Current year+0.08%
1 week 18.22
Extreme 18.22
18.42
1 month 16.28
Extreme 16.28
18.68
Current year 11.09
Extreme 11.09
21.01
1 year 11.09
Extreme 11.09
21.01
3 years 11.09
Extreme 11.09
52.69
5 years 11.09
Extreme 11.09
67.59
10 years 7.44
Extreme 7.44
90.92
Manager TitleAgeSince
Chief Executive Officer 67 26/06/2018
Director of Finance/CFO 63 01/12/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 81 17/07/1996
Director/Board Member 58 03/12/2014
Chairman 76 17/12/2024
Date Insider Type Main position Quantity % Market Cap.
06/07Sell

Executive/Senior Manager

-1,000 0.0050%
01/07Sell

Founder

-4,177 0.0207%
16/06Fiscal year

Executive/Senior Manager

22,050 0.1094%
Change 5-day change 1-year change 3-year change Capi.($)
+0.05%-0.63%+4.44%-61.15% 37Cr
+3.31%+1.86%-30.71%-6.30% 3.09TCr
+0.97%-5.09%-37.30%+211.69% 1.43TCr
+1.42%-2.52%-21.53%+73.05% 564.42Cr
-2.02%-3.54% - - 230.44Cr
+3.66%+2.94%+68.92%-36.54% 204.29Cr
-0.38%-15.66% - - 183.64Cr
-0.14%-4.46%-29.81% - 109.24Cr
-2.81%-6.03%+44.15%+105.75% 95Cr
-0.94%+0.78%-34.80%+252.82% 83Cr
Average +0.41%-3.56%-4.58%+77.04% 602.73Cr
Weighted average by Cap. +2.12%-3.20%-26.39%+62.91%

Financials

2026 *2027 *
Net sales 8.19Cr 7.18Cr 6.65Cr 6.12Cr 12Cr 783.62Cr 12Cr 79Cr 31Cr 384.82Cr 31Cr 30Cr 1.33TCr 8.63Cr 7.57Cr 7.01Cr 6.45Cr 12Cr 825.6Cr 12Cr 84Cr 33Cr 405.43Cr 32Cr 32Cr 1.4TCr
Net income 95.34L 83.62L 77.45L 71.26L 1.35Cr 91Cr 1.37Cr 9.23Cr 3.62Cr 45Cr 3.58Cr 3.5Cr 154.75Cr 1.02Cr 89.3L 82.71L 76.1L 1.44Cr 97Cr 1.47Cr 9.86Cr 3.87Cr 48Cr 3.82Cr 3.74Cr 165.26Cr
Net Debt - -
Logo Simulations Plus, Inc.
Simulations Plus, Inc. specializes in model-informed and artificial intelligence (AI)-accelerated drug development. The Company helps its clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through science-based software and consulting solutions. The Company’s segments include Software and Services. The Company's Software segment supports pharmaceutical research, development, and commercialization through simulation, modeling, and AI-driven prediction. Its main products include GastroPlus, ADMET Predictor, MonolixSuite, and others for disease modeling and training, as well as Pro-ficiency for clinical operations. Its Services segment includes advanced consulting services across the entire drug development lifecycle. Its scientists and engineers specialize in drug discovery, pharmacokinetics, pharmacodynamics, drug modeling, clinical trial data analysis, regulatory strategy, and medical communications.
Employees
213
Date Price Change Volume
14/26/14 $18.25 +0.03% 3,10,512
10/26/10 $18.24 -0.55% 4,23,570
09/26/09 $18.34 +0.38% 4,03,218
08/26/08 $18.27 -0.05% 3,97,537
07/26/07 $18.28 -0.44% 3,52,032
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
18.24USD
Average target price
17.25USD
Spread / Average Target
-5.43%

Quarterly revenue - Rate of surprise